Form 4: ACM Research CEO David Wang Sells 56,250 Shares Under 10b5-1 Trading Plan

ACM Research CEO David Wang sold 56,250 shares of Class A Common Stock at an average price of $17.44, according to a recent SEC filing.

Summary

• David H. Wang, CEO of ACM Research, sold 56,250 shares of Class A Common Stock on November 29, 2024.
• The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 14, 2024, and amended on August 13, 2024.
• The shares were sold at a weighted average price of $17.44, with individual transaction prices ranging from $17.12 to $17.65.
• Following the transaction, Mr. Wang directly owns 598,006 shares of Class A Common Stock.
• He also indirectly owns shares through his wife, daughter, and family trusts, totaling 945,840 shares.

Sentiment

Score: 5

Explanation: The document reflects a routine insider transaction under a pre-arranged plan, which is neither particularly positive nor negative.

Risks

• Sales by insiders, even under pre-arranged plans, can sometimes be perceived negatively by the market.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and these transactions are closely monitored by regulators and investors. Rule 10b5-1 plans are often used by executives to avoid accusations of trading on inside information.

Comparison to Industry Standards

• Sales by executives are common and are often part of pre-planned strategies, such as 10b5-1 plans, to diversify their holdings.
• The volume of shares sold by David Wang is not unusual for a CEO of a company of ACM Research's size.
• Comparable companies often see similar insider trading activity, with executives selling shares for personal financial planning.

Stakeholder Impact

• The sale may have a minor impact on shareholder sentiment, but it is unlikely to cause significant concern given the pre-planned nature of the transaction.

Key Dates

Keywords

ACM Research, David Wang, insider trading, SEC Form 4, stock sale, Rule 10b5-1, executive, share transaction